{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-155023","form_type":"8-K","ticker":"KLRS","cik":"0001754068","company_name":"Kalaris Therapeutics, Inc.","filed_at":"2022-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.138001+00:00","generated_at":"2026-06-25T09:21:12.374830+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"AlloVir stockholders elect Sinha and Brenner as Class II directors; ratify Deloitte","bullets":["Vikas Sinha elected with 47,229,880 for, 4,036,755 withhold, 10,745,678 broker non-votes.","Malcolm Brenner elected with 48,449,496 for, 2,817,139 withhold, 10,745,678 broker non-votes.","Ratification of Deloitte & Touche as auditor approved: 61,754,011 for, 250,317 against, 7,985 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-155023","json":"https://secwatch.observer/filing/0001193125-22-155023.json","markdown":"https://secwatch.observer/filing/0001193125-22-155023.md","text":"https://secwatch.observer/filing/0001193125-22-155023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1754068/000119312522155023/0001193125-22-155023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1754068/000119312522155023/d346922d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T09:21:12.374830+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}